Literature DB >> 14576188

Expression and distribution of MAL2, an essential element of the machinery for basolateral-to-apical transcytosis, in human thyroid epithelial cells.

Mónica Marazuela1, Fernando Martín-Belmonte, María Angeles García-López, Juan F Aranda, María C de Marco, Miguel A Alonso.   

Abstract

Polarized transport of newly synthesized proteins to the apical surface of epithelial cells takes place by a direct pathway from the Golgi or by an indirect route involving the delivery of the protein to the basolateral surface, followed by its endocytosis and transport across the cell. The indirect pathway, named transcytosis, is also used to translocate external material across the cell. MAL, a raft-associated integral membrane protein required for the direct apical route, is known to be expressed in the thyroid epithelium. MAL2, a member of the MAL protein family, has been recently identified as an essential component of the machinery for the transcytotic route in human hepatoma cells. Herein, we have investigated the expression and distribution of MAL2 in the human thyroid. MAL2 mRNA species were detected in the thyroid. Immunohistochemical analysis of thyroid follicles indicated that, in contrast to MAL, which predominantly distributed to the Golgi region, MAL2 distributed to the apical membrane. Biochemical analysis in primary thyrocyte cultures indicated that MAL2 exclusively resides in raft membranes. Confocal immunofluorescence analysis of thyrocyte cultures revealed that MAL2 predominantly localized in a subapical endosome compartment that was positive for Rab11a. Alterations in MAL2 expression, distribution, and appearance were found in specific types of follicular cell-derived carcinomas. Although the role of MAL2 has not been directly addressed in this study, the simultaneous expression of MAL and MAL2 suggests that traffic to the apical membrane in thyrocytes may rely on MAL for the direct route and on MAL2 for the transcytotic pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576188     DOI: 10.1210/en.2003-0652

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  MAL2 selectively regulates polymeric IgA receptor delivery from the Golgi to the plasma membrane in WIF-B cells.

Authors:  Julie G In; Pamela L Tuma
Journal:  Traffic       Date:  2010-05-07       Impact factor: 6.215

Review 2.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

3.  MAL, but not MAL2, expression promotes the formation of cholesterol-dependent membrane domains that recruit apical proteins.

Authors:  Sai P Ramnarayanan; Pamela L Tuma
Journal:  Biochem J       Date:  2011-11-01       Impact factor: 3.857

Review 4.  Membrane Transport across Polarized Epithelia.

Authors:  Maria Daniela Garcia-Castillo; Daniel J-F Chinnapen; Wayne I Lencer
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-09-01       Impact factor: 10.005

5.  Serine/threonine kinase 16 and MAL2 regulate constitutive secretion of soluble cargo in hepatic cells.

Authors:  Julie G In; Anneliese C Striz; Antonio Bernad; Pamela L Tuma
Journal:  Biochem J       Date:  2014-10-15       Impact factor: 3.857

6.  Clustering and lateral concentration of raft lipids by the MAL protein.

Authors:  Lee Goldstein Magal; Yakey Yaffe; Jeanne Shepshelovich; Juan Francisco Aranda; Maria del Carmen de Marco; Katharina Gaus; Miguel Angel Alonso; Koret Hirschberg
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

7.  MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.

Authors:  Yuanzhang Fang; Lifei Wang; Changlin Wan; Yifan Sun; Kevin Van der Jeught; Zhuolong Zhou; Tianhan Dong; Ka Man So; Tao Yu; Yujing Li; Haniyeh Eyvani; Austyn B Colter; Edward Dong; Sha Cao; Jin Wang; Bryan P Schneider; George E Sandusky; Yunlong Liu; Chi Zhang; Xiongbin Lu; Xinna Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

8.  T cell differentiation protein 2 facilitates cell proliferation by enhancing mTOR-mediated ribosome biogenesis in non-small cell lung cancer.

Authors:  Zhenying Lian; Xingyu Yan; Yutao Diao; Dayong Cui; Hongyan Liu
Journal:  Discov Oncol       Date:  2022-04-18

9.  Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells.

Authors:  Susan Fanayan; Mona Shehata; Annelies P Agterof; Michael A McGuckin; Miguel A Alonso; Jennifer A Byrne
Journal:  BMC Cell Biol       Date:  2009-01-28       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.